Skip to main content
Top
Published in: AIDS and Behavior 7/2019

01-07-2019 | Human Immunodeficiency Virus | Original Paper

Predictors of PrEP Uptake Among Patients with Equivalent Access

Authors: Sarit A. Golub, Rachel A. Fikslin, Matthew H. Goldberg, Stephanie M. Peña, Asa Radix

Published in: AIDS and Behavior | Issue 7/2019

Login to get access

Abstract

Increasing PrEP adoption for eligible individuals is critical, but limited research has examined individual-level factors that might be amenable to educational or behavioral intervention. Using data from a PrEP demonstration project conducted at a community health center, we examined differences in behavioral and psychosocial factors between patients offered PrEP who chose to accept it and those who declined. In a multivariable model, the odds of accepting PrEP were higher among those with an HIV-positive main partner, greater risk behavior in the past 3 months, and higher HIV risk perception. PrEP adoption was positively associated with PrEP adherence self-efficacy and negatively associated with perceived sensitivity to medicines. These psychological variables were associated with measures of PrEP- and HIV-related stigma. In the multivariable model, there were no differences in PrEP adoption by demographic factors or socioeconomic status. Data suggest that patients’ decisions about PrEP uptake may be impacted not only by objective and subjective HIV risk, but also by psychological variables such as stigma beliefs, medication beliefs, and self-efficacy.
Literature
1.
go back to reference Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2016. HIV Surveill Rep. 2017;28:1–125. Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2016. HIV Surveill Rep. 2017;28:1–125.
2.
go back to reference US Food and Drug Administration. Truvada for PrEP fact sheet: ensuring safe and proper use. 2014;1–2. US Food and Drug Administration. Truvada for PrEP fact sheet: ensuring safe and proper use. 2014;1–2.
3.
go back to reference Smith DK, Van Handel M, Wolitski RJ, Stryker JE, Hall HI, Prejean J, et al. Vital signs: estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition—United States, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(46):1291–5.CrossRefPubMed Smith DK, Van Handel M, Wolitski RJ, Stryker JE, Hall HI, Prejean J, et al. Vital signs: estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition—United States, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(46):1291–5.CrossRefPubMed
4.
go back to reference Parsons JT, Rendina HJ, Lassiter JM, Whitfield TH, Starks TJ, Grov C. Uptake of HIV pre-exposure prophylaxis (PrEP) in a national cohort of gay and bisexual men in the United States. JAIDS J Acquir Immune Defic Syndr. 2017;74(3):285–92.CrossRefPubMed Parsons JT, Rendina HJ, Lassiter JM, Whitfield TH, Starks TJ, Grov C. Uptake of HIV pre-exposure prophylaxis (PrEP) in a national cohort of gay and bisexual men in the United States. JAIDS J Acquir Immune Defic Syndr. 2017;74(3):285–92.CrossRefPubMed
5.
go back to reference Hood JE, Buskin SE, Dombrowski JC, Kern DA, Barash EA, Katzi DA, et al. Dramatic increase in preexposure prophylaxis use among MSM in Washington state. Aids. 2016;30(3):515–9.PubMed Hood JE, Buskin SE, Dombrowski JC, Kern DA, Barash EA, Katzi DA, et al. Dramatic increase in preexposure prophylaxis use among MSM in Washington state. Aids. 2016;30(3):515–9.PubMed
6.
go back to reference Holloway IW, Dougherty R, Gildner J, Beougher SC, Pulsipher C, Montoya JA, et al. Brief report: PrEP uptake, adherence, and discontinuation among California YMSM using geosocial networking applications. J Acquir Immune Defic Syndr. 2017;74(1):15–20.CrossRefPubMedPubMedCentral Holloway IW, Dougherty R, Gildner J, Beougher SC, Pulsipher C, Montoya JA, et al. Brief report: PrEP uptake, adherence, and discontinuation among California YMSM using geosocial networking applications. J Acquir Immune Defic Syndr. 2017;74(1):15–20.CrossRefPubMedPubMedCentral
8.
go back to reference Cahill S, Taylor SW, Elsesser SA, Mena L, Hickson D, Mayer KH. Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in black compared to white gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts. AIDS Care. 2017;29(11):1351–8.CrossRefPubMedPubMedCentral Cahill S, Taylor SW, Elsesser SA, Mena L, Hickson D, Mayer KH. Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in black compared to white gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts. AIDS Care. 2017;29(11):1351–8.CrossRefPubMedPubMedCentral
9.
go back to reference Pingel ES, Rolle C-P, Kelley C, Rosenberg E, Stephenson R, Sullivan P, et al. O02.4 It’s just not for me: exploring low prep uptake among young black men who have sex with men in the Southern United States. Sex Trans Infect. 2017;93(Suppl 2):A4. Pingel ES, Rolle C-P, Kelley C, Rosenberg E, Stephenson R, Sullivan P, et al. O02.4 It’s just not for me: exploring low prep uptake among young black men who have sex with men in the Southern United States. Sex Trans Infect. 2017;93(Suppl 2):A4.
11.
go back to reference Saunders JB, Aasland OG, Babor TF, De la Fuente JR, Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction. 1993;88(6):791–804.CrossRefPubMed Saunders JB, Aasland OG, Babor TF, De la Fuente JR, Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction. 1993;88(6):791–804.CrossRefPubMed
12.
go back to reference Golub SA, Gamarel KE. Psychometric evaluation of the Condom Barriers and Motivations Scale (CBMS). J Behav Med. 2017;40(3):494–505.CrossRefPubMed Golub SA, Gamarel KE. Psychometric evaluation of the Condom Barriers and Motivations Scale (CBMS). J Behav Med. 2017;40(3):494–505.CrossRefPubMed
13.
go back to reference Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Pat Care STDS. 2013;27(4):248–54.CrossRef Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Pat Care STDS. 2013;27(4):248–54.CrossRef
14.
go back to reference Champion VL. Instrument development for health belief model constructs. Adv Nurs Sci. 1984;6:73–85.CrossRef Champion VL. Instrument development for health belief model constructs. Adv Nurs Sci. 1984;6:73–85.CrossRef
15.
go back to reference Starks TJ, Rendina HJ, Breslow AS, Parsons JT, Golub SA. The psychological cost of anticipating HIV stigma for HIV-negative gay and bisexual men. AIDS Behav. 2013;17(8):2732–41.CrossRefPubMed Starks TJ, Rendina HJ, Breslow AS, Parsons JT, Golub SA. The psychological cost of anticipating HIV stigma for HIV-negative gay and bisexual men. AIDS Behav. 2013;17(8):2732–41.CrossRefPubMed
17.
go back to reference Horne R, Faasse K, Cooper V, Diefenbach MA, Leventhal H, Leventhal E, et al. The perceived sensitivity to medicines (PSM) scale: an evaluation of validity and reliability. Br J Health Psychol. 2013;18(1):18–30.CrossRefPubMed Horne R, Faasse K, Cooper V, Diefenbach MA, Leventhal H, Leventhal E, et al. The perceived sensitivity to medicines (PSM) scale: an evaluation of validity and reliability. Br J Health Psychol. 2013;18(1):18–30.CrossRefPubMed
18.
go back to reference Johnson MO, Neilands TB, Dilworth SE, Morin SF, Remien RH, Chesney MA. The role of self-efficacy in HIV treatment adherence: validation of the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES). J Behav Med. 2007;30(5):359–70.CrossRefPubMedPubMedCentral Johnson MO, Neilands TB, Dilworth SE, Morin SF, Remien RH, Chesney MA. The role of self-efficacy in HIV treatment adherence: validation of the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES). J Behav Med. 2007;30(5):359–70.CrossRefPubMedPubMedCentral
19.
go back to reference Tabachnick BG, Fidell LS. Using multivariate statistics. Boston: Allyn & Bacon/Pearson Education; 2007. Tabachnick BG, Fidell LS. Using multivariate statistics. Boston: Allyn & Bacon/Pearson Education; 2007.
20.
go back to reference Hayes AF. Introduction to mediation, moderation, and conditional process analysis: a regression-based approach. New York: Guilford Publications; 2017. Hayes AF. Introduction to mediation, moderation, and conditional process analysis: a regression-based approach. New York: Guilford Publications; 2017.
21.
go back to reference Sevelius JM, Keatley J, Calma N, Arnold E. ‘I am not a man’: trans-specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health. 2016;11(7–8):1060–75.CrossRefPubMed Sevelius JM, Keatley J, Calma N, Arnold E. ‘I am not a man’: trans-specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health. 2016;11(7–8):1060–75.CrossRefPubMed
22.
go back to reference Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2015. HIV Surveillance Report. 2016;27:1–114. Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2015. HIV Surveillance Report. 2016;27:1–114.
23.
go back to reference Sen S, Nguyen HD, Kim SY, Aguilar J. HIV knowledge, risk behavior, stigma, and their impact on HIV testing among Asian American and Pacific Islanders: a review of literature. Soc Work Public Health. 2017;32(1):11–29.CrossRefPubMed Sen S, Nguyen HD, Kim SY, Aguilar J. HIV knowledge, risk behavior, stigma, and their impact on HIV testing among Asian American and Pacific Islanders: a review of literature. Soc Work Public Health. 2017;32(1):11–29.CrossRefPubMed
25.
go back to reference Golub SA, Gamarel KE. The impact of anticipated HIV stigma on delays in HIV testing behaviors: findings from a community-based sample of men who have sex with men and transgender women in New York City. AIDS Pat Care STDs. 2013;27(11):621–7.CrossRef Golub SA, Gamarel KE. The impact of anticipated HIV stigma on delays in HIV testing behaviors: findings from a community-based sample of men who have sex with men and transgender women in New York City. AIDS Pat Care STDs. 2013;27(11):621–7.CrossRef
26.
go back to reference Earnshaw VA, Smith LR, Chaudoir SR, Lee I-C, Copenhaver MM. Stereotypes about people living with HIV: implications for perceptions of HIV risk and testing frequency among at-risk populations. AIDS Educ Prev. 2012;24(6):574–81.CrossRefPubMedPubMedCentral Earnshaw VA, Smith LR, Chaudoir SR, Lee I-C, Copenhaver MM. Stereotypes about people living with HIV: implications for perceptions of HIV risk and testing frequency among at-risk populations. AIDS Educ Prev. 2012;24(6):574–81.CrossRefPubMedPubMedCentral
27.
go back to reference Young SD, Nussbaum AD, Monin B. Potential moral stigma and reactions to sexually transmitted diseases: evidence for a disjunction fallacy. Pers Soc Psychol Bull. 2007;33(6):789–99.CrossRefPubMed Young SD, Nussbaum AD, Monin B. Potential moral stigma and reactions to sexually transmitted diseases: evidence for a disjunction fallacy. Pers Soc Psychol Bull. 2007;33(6):789–99.CrossRefPubMed
28.
29.
go back to reference Fisher WA, Fisher JD, Harman J. The information–motivation–behavioral skills model: a general social psychological approach to understanding and promoting health behavior. Soc Psychol Found Health Illn. 2003;1:82–106.CrossRef Fisher WA, Fisher JD, Harman J. The information–motivation–behavioral skills model: a general social psychological approach to understanding and promoting health behavior. Soc Psychol Found Health Illn. 2003;1:82–106.CrossRef
30.
go back to reference Faasse K, Grey A, Horne R, Petrie KJ. High perceived sensitivity to medicines is associated with higher medical care utilisation, increased symptom reporting and greater information-seeking about medication. Pharmacoepidemiol Drug Saf. 2015;24(6):592–9.CrossRefPubMed Faasse K, Grey A, Horne R, Petrie KJ. High perceived sensitivity to medicines is associated with higher medical care utilisation, increased symptom reporting and greater information-seeking about medication. Pharmacoepidemiol Drug Saf. 2015;24(6):592–9.CrossRefPubMed
Metadata
Title
Predictors of PrEP Uptake Among Patients with Equivalent Access
Authors
Sarit A. Golub
Rachel A. Fikslin
Matthew H. Goldberg
Stephanie M. Peña
Asa Radix
Publication date
01-07-2019
Publisher
Springer US
Published in
AIDS and Behavior / Issue 7/2019
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-018-2376-y

Other articles of this Issue 7/2019

AIDS and Behavior 7/2019 Go to the issue